![Medical Technology segment of ZEISS]({"xsmall":"https://www.zeiss.com/content/dam/med-hcp/reference-master/about-us/images/zeiss-meditec_about-us.jpg/_jcr_content/renditions/original.image_file.100.33.0,70,1920,710.file/zeiss-meditec_about-us.jpg","small":"https://www.zeiss.com/content/dam/med-hcp/reference-master/about-us/images/zeiss-meditec_about-us.jpg/_jcr_content/renditions/original.image_file.360.120.0,70,1920,710.file/zeiss-meditec_about-us.jpg","medium":"https://www.zeiss.com/content/dam/med-hcp/reference-master/about-us/images/zeiss-meditec_about-us.jpg/_jcr_content/renditions/original.image_file.768.256.0,70,1920,710.file/zeiss-meditec_about-us.jpg","large":"https://www.zeiss.com/content/dam/med-hcp/reference-master/about-us/images/zeiss-meditec_about-us.jpg/_jcr_content/renditions/original.image_file.1024.341.0,70,1920,710.file/zeiss-meditec_about-us.jpg","xlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/about-us/images/zeiss-meditec_about-us.jpg/_jcr_content/renditions/original.image_file.1280.427.0,70,1920,710.file/zeiss-meditec_about-us.jpg","xxlarge":"https://www.zeiss.com/content/dam/med-hcp/reference-master/about-us/images/zeiss-meditec_about-us.jpg/_jcr_content/renditions/original.image_file.1440.480.0,70,1920,710.file/zeiss-meditec_about-us.jpg","max":"https://www.zeiss.com/content/dam/med-hcp/reference-master/about-us/images/zeiss-meditec_about-us.jpg/_jcr_content/renditions/original.image_file.1920.640.0,70,1920,710.file/zeiss-meditec_about-us.jpg"} "Medical Technology segment of ZEISS")
Medical Technology segment of ZEISS
We improve the quality of life of patients and drive the progress, efficiency and access to healthcare.
Company overview
|
|
|
|---|---|
|
Owner
|
The Medical Technology activities of ZEISS are today largely bundled under the umbrella of the TecDAX-listed company Carl Zeiss Meditec AG in which Carl Zeiss AG holds ca. 59 percent interest.
|
|
Location
|
Besides its headquarters in Jena/Germany, the Carl Zeiss Meditec AG has subsidiaries in the USA, Japan, Germany, Spain, France, Turkey and UK. Additional ZEISS Research and Development Centers in India and China strengthen the company's presence in these rapidly developing economies. In other countries the company makes use of the vaste distribution network of ZEISS.
|
|
Management board
|
Dr. Markus Weber (President and CEO)
|
|
Justus Felix Wehmer (CFO) |
|
|
Revenue
|
The Carl Zeiss Meditec Group generated revenue of €2,089.3m in fiscal year 2022/23 (to 30 September).1 |
|
Employees
|
Carl Zeiss Meditec Group has approximately 4,823 employees worldwide.1 |
Social commitment at ZEISS Medical Technology
We at ZEISS
Where we are and who we are
Your career at ZEISS
Join us and experience exceptional opportunities
-
1
Revenue and Number of employees deviate from the published figures of the Medical Technology Segment of Carl Zeiss AG as a result of different consolidation models.